COVID-19急诊患者精神障碍与物质使用障碍共病与住院风险
结果显示,共病患者住院概率显著高于无共病、仅PD或仅SUD患者,且SUD对住院的预测作用强于PD。
要点
- COVID-19急诊患者中18.6%有PD、4.6%有SUD、2.3%两者共病。
- PD与SUD共病者住院概率较无共病者加权平均高20个百分点。
- SUD对住院概率的预测作用强于PD,共病评估不可忽视。
核心结论
- 在COVID-19急诊成人患者中,PD与SUD共病者住院概率高于仅患任一障碍或无共病者。
- SUD与住院概率的关联强于PD。
- 忽视急诊COVID-19患者可能的PD和SUD共病会低估其住院可能性。
研究设计与样本
- 回顾性横断面研究,分析2020年4月至2021年8月美国970家急诊科和住院医院收治的成人(年龄≥18岁)COVID-19患者的出院数据。
主要发现
- 18.6%的患者有PD(平均年龄59.0岁;男性37.7%),4.6%有SUD(平均年龄50.1岁;男性61.7%),2.3%两者共病(平均年龄50.4岁;男性53.1%)。
- 最常见的PD为焦虑(12.9%)、重度抑郁(9.8%)、多种PD(≥2种,6.4%)和精神分裂症(1.4%)。
- 最常见的SUD涉及酒精(2.1%)、大麻(1.3%)、阿片类(1.0%)和多种SUD(≥2种,0.9%)。
- PTSD、精神分裂症、其他心境障碍或ADHD患者中SUD患病率均超过21%。
- 基于显著的特定PD-SUD配对(Q < .05),共病者住院概率较无共病者加权平均高20个百分点(范围6至36;IQR 16至25),较仅PD者高12个百分点(范围-4至31;IQR 8至16),较仅SUD者高4个百分点(范围-7至15;IQR -2至7)。
临床怎么用
- 在急诊COVID-19患者中应同时筛查和评估PD与SUD,以准确判断住院风险。
- SUD对住院概率的预测作用更强,临床需特别关注物质使用问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: During the COVID-19 pandemic, US emergency department (ED) visits for psychiatric disorders (PDs) and drug overdoses increased. Psychiatric disorders and substance use disorders (SUDs) independently increased the risk of COVID-19 hospitalization, yet their effect together is unknown. OBJECTIVE: To assess how comorbid PD and SUD are associated with the probability of hospitalization among ED patients with COVID-19. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study analyzed discharge data for adults (age ≥18 years) with a COVID-19 diagnosis treated in 970 EDs and inpatient hospitals in the United States from April 2020 to August 2021. EXPOSURES: Any past diagnosis of (1) SUD from opioids, stimulants, alcohol, cannabis, cocaine, sedatives, or other substances and/or (2) PD, including attention-deficit/hyperactivity disorder (ADHD), anxiety, bipolar disorder, major depression, other mood disorder, posttraumatic stress disorder (PTSD), or schizophrenia. MAIN OUTCOMES AND MEASURES: The main outcome was any hospitalization. Differences in probability of hospitalization were calculated to assess its association with both PD and SUD compared with PD alone, SUD alone, or neither condition. RESULTS: Of 1 274 219 ED patients with COVID-19 (mean [SD] age, 54.6 [19.1] years; 667 638 women [52.4%]), 18.6% had a PD (mean age, 59.0 years; 37.7% men), 4.6% had a SUD (mean age, 50.1 years; 61.7% men), and 2.3% had both (mean age, 50.4 years; 53.1% men). The most common PDs were anxiety (12.9%), major depression (9.8%), poly (≥2) PDs (6.4%), and schizophrenia (1.4%). The most common SUDs involved alcohol (2.1%), cannabis (1.3%), opioids (1.0%), and poly (≥2) SUDs (0.9%). Prevalence of SUD among patients with PTSD, schizophrenia, other mood disorder, or ADHD each exceeded 21%. Based on significant specific PD-SUD pairs (Q < .05), probability of hospitalization of those with both PD and SUD was higher than those with (1) neither condition by a weighted mean of 20 percentage points (range, 6 to 36; IQR, 16 to 25); (2) PD alone by 12 percentage points (range, -4 to 31; IQR, 8 to 16); and (3) SUD alone by 4 percentage points (range, -7 to 15; IQR, -2 to 7). Associations varied by types of PD and SUD. Substance use disorder was a stronger predictor of hospitalization than PD. CONCLUSIONS AND RELEVANCE: This study found that patients with both PD and SUD had a greater probability of hospitalization, compared with those with either disorder alone or neither disorder. Substance use disorders appear to have a greater association than PDs with the probability of hospitalization. Overlooking possible coexisting PD and SUD in ED patients with COVID-19 can underestimate the likelihood of hospitalization. Screening and assessment of both conditions are needed.
引用
- Schieber LZ, Dunphy C, Schieber RA, et al. Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021. JAMA Psychiatry. 2023. PMID: 36790774. doi:10.1001/jamapsychiatry.2022.5047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。